These 44 shared miRNAs were significantly associated with key aspects of breast cancer progression, including conditions such as progesterone receptor-negative breast cancer, estrogen receptor-negative breast cancer, HER2-negative breast cancer, ductal carcinoma of the breast, and invasive breast carcinoma, which are consistent with the subtype of breast cancer we studied. Here, PGR is linked to breast ductal adenocarcinoma.